REXULTI® (brexpiprazole) HCP

Rexulti® (brexpiprazole) hcp email format

Verified email-pattern data for Rexulti® (Brexpiprazole) Hcp is currently limited. You can still use the company insights and contact sections below.
REXULTI is available as 2 mg tablets as well as other dosage strengths. Please see IMPORTANT SAFETY INFORMATION by visiting https://tinyurl.com/26tdmdx4. Please see FULL PRESCRIBING INFORMATION, including BOXED WARNING by visiting tinyurl.com/yc6hwy2v. This page is not intended for the reporting of side effects associated with the use of REXULTI. To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at 1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch). This content is intended for U.S. HCPs. © 2023 Otsuka America Pharmaceutical, Inc. All rights reserved. April 2023 11US23EBP0103
Looking for a particular REXULTI® (brexpiprazole) HCP employee's phone or email?

Rexulti® (Brexpiprazole) Hcp Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant